- Q1 2024 Bristol-Myers Squibb Co Earnings Call TranscriptApr 25, 2024MXN770.15 (-7.62%)Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference TranscriptMar 14, 2024
- Bristol-Myers Squibb Co at Leerink Partners Global Biopharma Conference TranscriptMar 13, 2024
- Bristol-Myers Squibb Co at TD Cowen Health Care Conference TranscriptMar 04, 2024
- Q4 2023 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 02, 2024MXN839 (+1.64%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Bristol-Myers Squibb Co to Acquire Karuna Therapeutics Inc-M&A Call TranscriptDec 22, 2023
- Bristol-Myers Squibb Co at Jefferies London Healthcare Conference TranscriptNov 16, 2023
- Bristol-Myers Squibb Co at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Bristol-Myers Squibb Co Earnings Call TranscriptOct 26, 2023MXN981 (-4.97%)Earnings
- Bristol-Myers Squibb Co R&D Day TranscriptSep 14, 2023
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Bristol-Myers Squibb Co Earnings Call TranscriptJul 27, 2023MXN1025 (-4.38%)Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Bristol-Myers Squibb Co at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Bristol-Myers Squibb Co Virtual Investor Event: ASCO 2023 TranscriptJun 06, 2023
- Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Bristol-Myers Squibb Co Earnings Call TranscriptApr 27, 2023MXN1270.57Earnings
- Bristol-Myers Squibb Co at Cowen Health Care Conference TranscriptMar 07, 2023
- Bristol-Myers Squibb Co at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q4 2022 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 02, 2023MXN1353.11 (+1.91%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Bristol-Myers Squibb Co Earnings Call TranscriptOct 26, 2022MXN1485.79 (+2.12%)Earnings
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Bristol-Myers Squibb Co at Citi BioPharma Conference TranscriptSep 08, 2022
- Bristol-Myers Squibb Co Investor Event TranscriptAug 28, 2022
- Q2 2022 Bristol-Myers Squibb Co Earnings Call TranscriptJul 27, 2022MXN1516.88 (+0.66%)Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 02, 2022
- Bristol-Myers Squibb Co at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Bristol-Myers Squibb Co Earnings Call TranscriptApr 29, 2022MXN1540 (-3.14%)Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference - Fireside Chat TranscriptMar 16, 2022
- Bristol-Myers Squibb Co at Guggenheim Healthcare Talks: Targeted Protein Degradation Day (Virtual) - Fireside Chat TranscriptMar 16, 2022
- Q4 2021 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 04, 2022MXN1338 (+1.52%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Bristol-Myers Squibb Co Investor Event TranscriptNov 16, 2021
- Q3 2021 Bristol-Myers Squibb Co Earnings Call TranscriptOct 27, 2021MXN1140 (-3.23%)Earnings
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Bristol-Myers Squibb Co Earnings Call TranscriptJul 28, 2021MXN1368.01 (+1.33%)Earnings
- Bristol-Myers Squibb Co at William Blair Biotech Focus Conference (Virtual) TranscriptJul 14, 2021
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Bristol-Myers Squibb Co Investor Event to Discuss Data Presented at ASCO TranscriptJun 08, 2021
- Bristol-Myers Squibb Co at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 02, 2021
- Bristol-Myers Squibb Co at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Bristol-Myers Squibb Co at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Bristol-Myers Squibb Co at Truist Securities Life Sciences Summit (May Series) TranscriptMay 05, 2021
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 04, 2021
- Q1 2021 Bristol-Myers Squibb Co Earnings Call TranscriptApr 29, 2021MXN1260.9 (-4.84%)Earnings
- Bristol-Myers Squibb Co Virtual Investor Event to Discuss AAD VMX Highlights TranscriptApr 23, 2021
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Bristol-Myers Squibb Co at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Bristol-Myers Squibb Co at Raymond James Institutional Investors Conference (Virtual) TranscriptMar 02, 2021
- Bristol-Myers Squibb Co at Guggenheim Partners Healthcare Talks Oncology Days TranscriptFeb 12, 2021
- Q4 2020 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 04, 2021MXN1253 (-0.59%)Earnings
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- Q3 2020 Bristol-Myers Squibb Co Earnings Call TranscriptNov 05, 2020MXN1330 (-3.27%)Earnings
- Bristol-Myers Squibb Co Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia (ozanimod) in Ulcerative Colitis at UEG Week 2020 TranscriptOct 12, 2020
- Bristol-Myers Squibb Company, MyoKardia, Inc. - M&A Call TranscriptOct 05, 2020
- Bristol-Myers Squibb Co Investor Event at European Society of Medical Oncology TranscriptSep 21, 2020
- Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Bristol-Myers Squibb Co at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2020
- Q2 2020 Bristol-Myers Squibb Co Earnings Call TranscriptAug 06, 2020MXN1372 (+2.39%)Earnings
- Bristol-Myers Squibb Co Three-Part Investor Series: Immunology and Cardiovascular TranscriptJun 26, 2020
- Bristol-Myers Squibb Co Three-Part Investor Series: Hematology TranscriptJun 25, 2020
- Bristol-Myers Squibb Co Three-Part Investor Series: Early Pipeline and Immuno-Oncology TranscriptJun 22, 2020
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Bristol-Myers Squibb Co at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call TranscriptMay 13, 2020
- Q1 2020 Bristol-Myers Squibb Co Earnings Call TranscriptMay 07, 2020MXN1470 (-1.20%)Earnings
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 05, 2020
- Q4 2019 Bristol-Myers Squibb Co Earnings Call TranscriptFeb 06, 2020MXN1244 (+2.39%)Earnings
- Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session TranscriptJan 15, 2020
- Bristol-Myers Squibb Co at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Bristol-Myers Squibb Co at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top TranscriptJan 09, 2020
- Bristol-Myers Squibb Co to Hold Investor Webcast to Discuss ASH Highlights TranscriptDec 09, 2019
- Bristol-Myers Squibb Co at Wolfe Research Inaugural Healthcare Conference TranscriptNov 06, 2019
- Q3 2019 Bristol-Myers Squibb Co Earnings Call TranscriptOct 31, 2019MXN1109.4 (+1.22%)Earnings
- Bristol-Myers Squibb Co to Discuss ESMO Highlights Call TranscriptSep 28, 2019
- Bristol-Myers Squibb Co at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Bristol-Myers Squibb Co Earnings Call TranscriptJul 25, 2019MXN865 (+5.14%)Earnings
- Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Bristol-Myers Squibb Co Annual Shareholders Meeting TranscriptMay 29, 2019
- Bristol-Myers Squibb Co at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Q1 2019 Bristol-Myers Squibb Co Earnings Call TranscriptApr 25, 2019MXN867.15 (+1.11%)Earnings
- Bristol-Myers Squibb Co at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Bristol-Myers Squibb Co at Cowen Health Care Conference TranscriptMar 12, 2019
- Bristol-Myers Squibb Co at Guggenheim Partners Oncology Day TranscriptFeb 14, 2019
- Q4 2018 Bristol-Myers Squibb Co Earnings Call TranscriptJan 24, 2019MXN935 (-1.58%)Earnings
Bristol-Myers Squibb Co at Cowen Health Care Conference Transcript
So good morning. And we're thrilled to have Bristol-Myers Squibb with us at the Cowen Conference once again this year. Representing the company is Giovanni Caforio, who is Chairman and CEO; Tom Lynch, who's Executive Vice President and Chief Scientific Officer; Charlie Bancroft, who's Executive Vice President and CFO; and Chris Boerner, who is Executive Vice President and Chief Commercial Officer.
I mean, clearly, many investors continue to ponder the idea of Bristol-Myers Squibb acquiring Celgene. And 2 questions that we at Cowen have gotten consistently are, first, the merits of the transaction; and secondly, this notion of serial acquisitions, wouldn't have that been a better idea? And our response is there are clearly examples where 2 companies have come together and proven to be a stronger company as a result. I just think we need to all really give some thought to the fact that maybe Giovanni is absolutely right when he says this is a transformative acquisition done from a position of strength
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)